CAPTRUST FINANCIAL ADVISORS

Position in GEHC — GE HealthCare Technologies Inc.

CIK 1512024 RALEIGH, NC

Position in GEHC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,636,657

+$355,283 QoQ

Shares Held

51,091

+27.7% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 32% Shared 0% None 68%

Healthcare · as of Mar 31, 2026

CAPTRUST FINANCIAL ADVISORS holds $174,771,393 across 43 Medical Devices names. GEHC ranks #7 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	STE	STERIS plc	210,675	$46,586,562
2	ABT	Abbott Laboratories	451,752	$46,381,377
3	SYK	Stryker Corp	76,454	$25,122,019
4	MDT	Medtronic plc	231,208	$20,034,173
5	BSX	Boston Scientific Corp	90,594	$5,684,773
6	EW	Edwards Lifesciences Corp	56,646	$4,536,211
7	GEHC	GE HealthCare Technologies Inc. This page	51,091	$3,636,657
8	ZBH	Zimmer Biomet Holdings, Inc.	35,597	$3,218,680

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,636,657	51,091	+27.7%	Shares	Sole	2026-05-15
2025-12-31	$3,281,374	40,007	+7.3%	Shares	Sole	2026-02-17
2025-09-30	$2,801,230	37,300	+13.9%	Shares	Sole	2025-11-19
2025-06-30	$2,426,607	32,761	-5.8%	Shares	Sole	2025-08-15
2025-03-31	$2,805,641	34,762	-4.0%	Shares	Sole	2025-05-15
2024-12-31	$2,831,210	36,214	+8.6%	Shares	Sole	2025-02-14
2024-09-30	$3,130,179	33,353	+1.6%	Shares	Sole	2024-11-14
2024-06-30	$2,557,256	32,819	-0.9%	Shares	Sole	2024-08-15
2024-03-31	$3,011,393	33,125	-27.2%	Shares	Sole	2024-05-15
2023-12-31	$3,516,358	45,478	+3.7%	Shares	Sole	2024-02-14
2023-09-30	$2,984,370	43,862	+56.5%	Shares	Sole	2023-11-15
2023-06-30	$2,277,319	28,032	+2.8%	Shares	Sole	2023-08-15
2023-03-31	$2,237,614	27,278	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.